Cargando…

Cannabinoids in the Treatment of Epilepsy: Current Status and Future Prospects

Cannabidiol (CBD) is one of the prominent phytocannabinoids found in Cannabis sativa, differentiating from Δ(9)-tetrahydrocannabinol (THC) for its non-intoxicating profile and its antianxiety/antipsychotic effects. CBD is a multi-target drug whose anti-convulsant properties are supposed to be indepe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morano, Alessandra, Fanella, Martina, Albini, Mariarita, Cifelli, Pierangelo, Palma, Eleonora, Giallonardo, Anna Teresa, Di Bonaventura, Carlo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7012327/ https://www.ncbi.nlm.nih.gov/pubmed/32103958 http://dx.doi.org/10.2147/NDT.S203782

Ejemplares similares

Ictal epileptic headache revealing non convulsive status epilepticus in a case of eyelid myoclonia with absences
por: Fanella, Martina, et al.
Publicado: (2015)

The grey zone between autoimmune encephalitis and autoimmune‐associated epilepsy
por: Morano, Alessandra, et al.
Publicado: (2021)

Cannabis in epilepsy: From clinical practice to basic research focusing on the possible role of cannabidivarin
por: Morano, Alessandra, et al.
Publicado: (2016)

Functional Gastrointestinal Disorders in Patients With Epilepsy: Reciprocal Influence and Impact on Seizure Occurrence
por: Avorio, Federica, et al.
Publicado: (2021)

Dissecting the Molecular Determinants of GABA(A) Receptors Current Rundown, a Hallmark of Refractory Human Epilepsy
por: Cifelli, Pierangelo, et al.
Publicado: (2021)

Late-onset seizures and epilepsy: Electroclinical features suggestive of autoimmune etiology
por: Morano, Alessandra, et al.
Publicado: (2022)

Changes in the sensitivity of GABA(A) current rundown to drug treatments in a model of temporal lobe epilepsy
por: Cifelli, Pierangelo, et al.
Publicado: (2013)

Generalized Fast Discharges Along the Genetic Generalized Epilepsy Spectrum: Clinical and Prognostic Significance
por: Cerulli Irelli, Emanuele, et al.
Publicado: (2022)

Molecular Chaperones and miRNAs in Epilepsy: Pathogenic Implications and Therapeutic Prospects
por: Zummo, Leila, et al.
Publicado: (2021)

GABAergic Neurotransmission in Human Tissues Is Modulated by Cannabidiol
por: Ruffolo, Gabriele, et al.
Publicado: (2022)

Olfactory impairment in autoimmune encephalitis: another piece of the puzzle
por: Morano, Alessandra, et al.
Publicado: (2022)

Unexpected Effect of IL-1β on the Function of GABA(A) Receptors in Pediatric Focal Cortical Dysplasia
por: Alfano, Veronica, et al.
Publicado: (2022)

Progressive myoclonus epilepsies due to SEMA6B mutations. New variants and appraisal of published phenotypes
por: Castellotti, Barbara, et al.
Publicado: (2023)

Cannabinoids as therapeutic agents in cancer: current status and future implications
por: Chakravarti, Bandana, et al.
Publicado: (2014)

EEG Markers of Treatment Resistance in Idiopathic Generalized Epilepsy: From Standard EEG Findings to Advanced Signal Analysis
por: Cerulli Irelli, Emanuele, et al.
Publicado: (2022)

GABA(A) receptor function is enhanced by Interleukin-10 in human epileptogenic gangliogliomas and its effect is counteracted by Interleukin-1β
por: Ruffolo, Gabriele, et al.
Publicado: (2022)

Structural Cerebellar Abnormalities and Parkinsonism in Patients with 22q11.2 Deletion Syndrome
por: Piervincenzi, Claudia, et al.
Publicado: (2022)

Targeting Cannabinoid Receptors: Current Status and Prospects of Natural Products
por: An, Dongchen, et al.
Publicado: (2020)

Cannabinoid Formulations and Delivery Systems: Current and Future Options to Treat Pain
por: Stella, Barbara, et al.
Publicado: (2021)

Current Status and Future Objectives of Surgical Therapies for Epilepsy in Japan
por: MIKUNI, Nobuhiro, et al.
Publicado: (2021)

Progressive Myoclonus Epilepsies: Diagnostic Yield With Next-Generation Sequencing in Previously Unsolved Cases
por: Canafoglia, Laura, et al.
Publicado: (2021)

Phytocannabinoids in Neurological Diseases: Could They Restore a Physiological GABAergic Transmission?
por: Cifelli, Pierangelo, et al.
Publicado: (2020)

Cannabinoids in Audiogenic Seizures: From Neuronal Networks to Future Perspectives for Epilepsy Treatment
por: Lazarini-Lopes, Willian, et al.
Publicado: (2021)

Classical and Unexpected Effects of Ultra-Micronized PEA in Neuromuscular Function
por: Cifelli, Pierangelo, et al.
Publicado: (2022)

Adjunctive Brivaracetam in Focal Epilepsy: Real-World Evidence from the BRIVAracetam add-on First Italian netwoRk STudy (BRIVAFIRST)
por: Lattanzi, Simona, et al.
Publicado: (2021)

The current state and future perspectives of cannabinoids in cancer biology
por: Śledziński, Paweł, et al.
Publicado: (2018)

The current state and future perspectives of cannabinoids in cancer biology
Publicado: (2018)

Correction to: Adjunctive Brivaracetam in Focal Epilepsy: Real‑World Evidence from the BRIVAracetam add‑on First Italian netwoRk Study (BRIVAFIRST)
por: Lattanzi, Simona, et al.
Publicado: (2021)

Cannabinoids as anticancer drugs: current status of preclinical research
por: Hinz, Burkhard, et al.
Publicado: (2022)

Abnormalities of Cortical Sources of Resting State Delta Electroencephalographic Rhythms Are Related to Epileptiform Activity in Patients With Amnesic Mild Cognitive Impairment Not Due to Alzheimer's Disease
por: Babiloni, Claudio, et al.
Publicado: (2020)

Cannabinoids in the Treatment of Epilepsy: Hard Evidence at Last?
por: Perucca, Emilio
Publicado: (2017)

The Interplay between the Endocannabinoid System, Epilepsy and Cannabinoids
por: Kwan Cheung, Keith A., et al.
Publicado: (2019)

Allosteric Modulation of Cannabinoid Receptor 1—Current Challenges and Future Opportunities
por: Hryhorowicz, Szymon, et al.
Publicado: (2019)

Reduction in nosocomial infections during the COVID-19 era: a lesson to be learned
por: Cerulli Irelli, Emanuele, et al.
Publicado: (2020)

Holmium-166 Radioembolization: Current Status and Future Prospective
por: Stella, Martina, et al.
Publicado: (2022)

Effects of 3,4-diaminopyridine on myasthenia gravis: Preliminary results of an open-label study
por: Ceccanti, Marco, et al.
Publicado: (2022)

A Rare Case of Cannabinoid Hyperemesis Syndrome Secondary to Cannabidiol for Refractory Epilepsy
por: Katz, Daphna T., et al.
Publicado: (2023)

Deep Brain Stimulation for Refractory Temporal Lobe Epilepsy. Current Status and Future Trends
por: Velasco, Francisco, et al.
Publicado: (2022)

The clinical phenotype of autosomal dominant lateral temporal lobe epilepsy related to reelin mutations
por: Michelucci, Roberto, et al.
Publicado: (2017)

Latex Allergy: Current Status and Future Perspectives
por: Nucera, Eleonora, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_62vlmmqs4bavtukgns647rva8h